“Host-guest” interactions in Captisol®/Coumestrol inclusion complex: UV–vis, FTIR-ATR and Raman studies-Reference-Cited by-同舟云学术

“Host-guest” interactions in Captisol®/Coumestrol inclusion complex: UV–vis, FTIR-ATR and Raman studies

Published:2017-10 Issue: Volume:1146 Page:512-521
ISSN:0022-2860
Container-title:Journal of Molecular Structure
language:en
Short-container-title:Journal of Molecular Structure

Author:

Venuti Valentina,Stancanelli Rosanna^ORCID,Acri Giuseppe,Crupi Vincenza,Paladini Giuseppe,Testagrossa Barbara,Tommasini Silvana,Ventura Cinzia Anna,Majolino Domenico

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry

Reference59 articles.

1. Phytoestrogens and prostate cancer risk;Ganry;Prev. Med.,2005

2. Neurobehavioral actions of coumestrol and related isoflavonoids in rodents;Whitten;Neurotoxicol. Teratol.,2002

3. Estrogen receptor ligands. Part 1: the discovery of flavanoids with subtype selectivity;Chen;Bioorg. Med. Chem. Lett.,2004

4. Characterization of estrogenicity of phytoestrogens in an endometrial-derived experimental model;Hopert;Environ. Health Perspect.,1998

5. The phytoestrogen coumestrol is a naturally occurring antagonist of the human pregnane X receptor;Wang;Mol. Endocrinol.,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation, characterization, and in vitro cytogenotoxic evaluation of a novel dimenhydrinate-β-cyclodextrin inclusion complex;Biomolecules and Biomedicine;2024-05-30

2. Inclusion complexation and liposomal encapsulation of an isoniazid hydrazone derivative in cyclodextrin for pH-dependent controlled release;Journal of Drug Delivery Science and Technology;2023-03

3. Sulfobutylether-β-cyclodextrin: A functional biopolymer for drug delivery applications;Carbohydrate Polymers;2023-02

4. Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins;Biomolecules;2022-11-19

5. Chitosan/Cyclodextrin Nanospheres for Potential Nose-to-Brain Targeting of Idebenone;Pharmaceuticals;2022-09-28